{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:34:03Z","timestamp":1707525243796},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,18]]},"DOI":"10.7759\/cureus.45490","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T19:43:21Z","timestamp":1695066201000},"source":"Crossref","is-referenced-by-count":0,"title":["Pheochromocytoma: A Troublesome Tumor"],"prefix":"10.7759","author":[{"given":"Tirath","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah A","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Senior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M","family":"Millis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann HP","year":"2019","unstructured":"Neumann HP, Young WF Jr, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med. 2019, 381:552-65. 10.1056\/NEJMra1806651","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000251887.01885.54","article-title":"Pheochromocytoma: presentation, diagnosis and treatment","volume":"24","author":"Reisch N","year":"2006","unstructured":"Reisch N, Peczkowska M, Januszewicz A, Neumann HP. Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens. 2006, 24:2331-9. 10.1097\/01.hjh.0000251887.01885.54","journal-title":"J Hypertens"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2013.12.009","article-title":"Pheochromocytoma: a review","volume":"77","author":"Tsirlin A","year":"2014","unstructured":"Tsirlin A, Oo Y, Sharma R, Kansara A, Gliwa A, Banerji MA. Pheochromocytoma: a review. Maturitas. 2014, 77:229-38. 10.1016\/j.maturitas.2013.12.009","journal-title":"Maturitas"},{"key":"ref4","article-title":"Pheochromocytoma","author":"Manger WM","year":"2012","unstructured":"Manger WM, Gifford RJ. Pheochromocytoma. Springer Science & Business Media, 2012."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0013","article-title":"Pheochromocytoma: state-of-the-art and future prospects","volume":"24","author":"Bravo EL","year":"2003","unstructured":"Bravo EL, Tagle R. Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev. 2003, 24:539-53. 10.1210\/er.2002-0013","journal-title":"Endocr Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s003450050102","article-title":"Pheochromocytoma: evaluation, diagnosis, and treatment","volume":"17","author":"Walther MM","year":"1999","unstructured":"Walther MM, Keiser HR, Linehan WM. Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol. 1999, 17:35-9. 10.1007\/s003450050102","journal-title":"World J Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0396","article-title":"Pheochromocytoma: recommendations for clinical practice from the first International Symposium","volume":"3","author":"Pacak K","year":"2007","unstructured":"Pacak K, Eisenhofer G, Ahlman H, et al.. Pheochromocytoma: recommendations for clinical practice from the first International Symposium. Nat Clin Pract Endocrinol Metab. 2007, 3:92-102. 10.1038\/ncpendmet0396","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440290087009","article-title":"Metyrosine and pheochromocytoma","volume":"157","author":"Steinsapir J","year":"1997","unstructured":"Steinsapir J, Carr AA, Prisant LM, et al.. Metyrosine and pheochromocytoma. Arch Intern Med. 1997, 157:901-6. 10.1001\/archinte.1997.00440290087009","journal-title":"Arch Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-017-1299-y","article-title":"Thyrotoxic and pheochromocytoma multisystem crisis: a case report","volume":"11","author":"Suzuki K","year":"2017","unstructured":"Suzuki K, Miyake T, Okada H, et al.. Thyrotoxic and pheochromocytoma multisystem crisis: a case report. J Med Case Rep. 2017, 11:173. 10.1186\/s13256-017-1299-y","journal-title":"J Med Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3625","article-title":"Changes in energy metabolism in pheochromocytoma","volume":"98","author":"Petr\u00e1k O","year":"2013","unstructured":"Petr\u00e1k O, Haluz\u00edkov\u00e1 D, Kav\u00e1lkov\u00e1 P, et al.. Changes in energy metabolism in pheochromocytoma. J Clin Endocrinol Metab. 2013, 98:1651-8. 10.1210\/jc.2012-3625","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","article-title":"Panic disorder","volume":"368","author":"Roy-Byrne PP","year":"2006","unstructured":"Roy-Byrne PP, Craske MG, Stein MB. Panic disorder. Lancet. 2006, 368:1023-32. 10\/1016\/S0140-6736(06)69418-X","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2012.01.009","article-title":"Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background","volume":"205","author":"Fishbein L","year":"2012","unstructured":"Fishbein L, Nathanson KL. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genet. 2012, 205:1-11. 10.1016\/j.cancergen.2012.01.009","journal-title":"Cancer Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg024","article-title":"Pheochromocytoma: the expanding genetic differential diagnosis","volume":"95","author":"Bryant J","year":"2003","unstructured":"Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL. Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst. 2003, 95:1196-204. 10.1093\/jnci\/djg024","journal-title":"J Natl Cancer Inst"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti D","year":"2001","unstructured":"Astuti D, Latif F, Dallol A, et al.. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. 2001, 69:49-54. 10.1086\/321282","journal-title":"Am J Hum Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-020-09630-8","article-title":"Pathology of pheochromocytoma and paraganglioma","volume":"31","author":"Tischler AS","year":"2020","unstructured":"Tischler AS, de Krijger RR, Gill AJ. Pathology of pheochromocytoma and paraganglioma. Endocr Pathol. 2020, 31:93-105. 10.1007\/s12022-020-09630-8","journal-title":"Endocr Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia PLM","year":"2014","unstructured":"Dahia PLM. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer. 2014, 14:108-19. 10.1038\/nrc3648","journal-title":"Nat Rev Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-3140","article-title":"DNA methylation signature reveals new insights into the molecular mechanisms of pheochromocytoma and paraganglioma","volume":"23","author":"Buffet A","year":"2017","unstructured":"Buffet A, Morin A, Castro-Vega LJ, et al.. DNA methylation signature reveals new insights into the molecular mechanisms of pheochromocytoma and paraganglioma. Clin Cancer Res. 2017, 23:4690-701. 10.1158\/1078-0432.CCR-16-3140","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","author":"Burnichon N","year":"2011","unstructured":"Burnichon N, Vescovo L, Amar L, et al.. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum Mol Genet. 2011, 20:3974-85. 10.1093\/hmg\/ddr324","journal-title":"Hum Mol Genet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-20-0086","article-title":"Genetics and epigenetics of pheochromocytoma and paraganglioma","volume":"27","author":"Papathomas TG","year":"2020","unstructured":"Papathomas TG, Oudijk L, Persu A, et al.. Genetics and epigenetics of pheochromocytoma and paraganglioma. Endocr Relat Cancer. 2020, 27:435-55. 10.1530\/ERC-20-0086","journal-title":"Endocr Relat Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/166459-pheochromocytoma-a-troublesome-tumor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:47Z","timestamp":1707509147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/166459-pheochromocytoma-a-troublesome-tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.45490","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,18]]}}}